Soleus Capital Management, L.P.

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1802630 GREENWICH, CT

Position in PRAX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$106,489,272

-$491,326 QoQ

Shares Held

330,517

-8.9% QoQ

Ownership

1.19%

of shares outstanding

% of Portfolio

4.24%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Soleus Capital Management, L.P. holds $1,422,770,178 across 59 Biotechnology names. PRAX ranks #4 (7.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	1,153,087	$297,865,433
2	CELC	Celcuity Inc.	1,284,378	$146,598,904
3	TGTX	Tg Therapeutics, Inc.	4,029,319	$133,853,977
4	PRAX	Praxis Precision Medicines, Inc. This page	330,517	$106,489,272
5	VCEL	Vericel Corp	2,549,079	$82,003,871
6	GERN	Geron Corp	41,508,659	$61,847,901
7	IMUX	Immunic, Inc.	4,500,000	$49,950,000
8	EWTX	Edgewise Therapeutics, Inc.	1,449,915	$45,672,322

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$106,489,272	330,517	-8.9%	Shares	Sole	2026-05-14
2025-12-31	$106,980,598	362,966	-57.8%	Shares	Sole	2026-02-12
2025-09-30	$45,535,798	859,166	-11.1%	Shares	Sole	2025-11-14
2025-06-30	$40,651,417	966,740	-15.2%	Shares	Sole	2025-08-15
2025-03-31	$43,161,953	1,139,740	+368.0%	Shares	Sole	2025-05-15
2024-12-31	$18,742,838	243,540	-6.1%	Shares	Sole	2025-02-14
2024-09-30	$14,925,760	259,398	-51.3%	Shares	Sole	2024-11-14
2024-06-30	$22,045,500	533,015	+1330.2%	Shares	Sole	2024-08-14
2024-03-31	$2,274,093	37,268	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.